[National meetings for complex cases in pediatric radiation oncology: Back on six years experience].
Réunions nationales de cas complexes en radiothérapie pédiatrique : retour sur six années d’expérience.
Cancer
Collegial
Collégial
Pediatric
Pédiatrie
Radiation therapy
Radiothérapie
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
07
03
2022
revised:
07
04
2022
accepted:
14
04
2022
pubmed:
9
8
2022
medline:
26
10
2022
entrez:
8
8
2022
Statut:
ppublish
Résumé
Pediatric cancers are rare, representing almost 2,500 new cases each year in France meaning 1% of all cancers. Since 2012, a twice-monthly national web-based conference was held in France. Any patient with a pediatric type cancer requiring radiotherapy can be discussed. It aims at answering the physician with specific radiation therapy questions on rare and complex indications, at promoting the use of referential and the inclusion into clinical protocols. From 2012 to 2018, 1,078 cases were discussed for 940 patients in 142 meetings. Mean age was 10 years old (4 months to 45 years). The mean number of attendants was 6 (2 to 32). We review in this paper the main clinical features discussed in the web-conference and the decision of the web-conference. In 85% cases, the first treatment proposed was mostly accepted, but in 15%, other proposals were done (modifications of target volumes, doses or indications). Between 2012 and 2018, more than 1,000 pediatric irradiation cases were discussed in our web-based conference leading to 15% of change in radiation protocol. The rarity and the complexity of these situations need those meetings. They provide a place to improve the global knowledge and the quality of the treatments provided.
Identifiants
pubmed: 35940945
pii: S0007-4551(22)00188-6
doi: 10.1016/j.bulcan.2022.04.011
pii:
doi:
Types de publication
Review
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
1177-1184Informations de copyright
Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.